Corcept Therapeutics
CORT
#1629
Rank
NZ$23.43 B
Marketcap
NZ$216.81
Share price
0.00%
Change (1 day)
73.58%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): NZ$11.97 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.83 Billion. In 2025 the company made an earning of NZ$80.14 Million a decrease over its 2024 earnings that were of NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$11.97 M-85.05%
2025 NZ$80.14 M-67.29%
2024 NZ$0.24 B27.66%
2023 NZ$0.19 B-4.75%
2022 NZ$0.20 B-9.51%
2021 NZ$0.22 B-2.91%
2020 NZ$0.22 B14.87%
2019 NZ$0.19 B24.71%
2018 NZ$0.16 B69.32%
2017 NZ$94.55 M419.26%
2016 NZ$18.21 M-395.64%
2015 -NZ$6.16 Million-87.53%
2014 -NZ$49.42 Million-33.44%
2013 -NZ$74.24 Million
2011 -NZ$57.85 Million17.84%
2010 -NZ$49.09 Million35.5%
2009 -NZ$36.23 Million2.84%
2008 -NZ$35.23 Million60.81%
2007 -NZ$21.91 Million-52.14%
2006 -NZ$45.77 Million20.91%
2005 -NZ$37.86 Million31.87%
2004 -NZ$28.71 Million60.54%
2003 -NZ$17.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.88 B 409,080.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.76 B 242,241.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.35 B 107,737.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$60.10 B 524,421.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.75 B 119,962.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.30 B 185,848.48%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$87.05 Million-859.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.14 B 1,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B 2,228.02%๐Ÿ‡บ๐Ÿ‡ธ USA